-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.00308.16% Upside
Lipella Pharmaceuticals Inc. Frequently Asked Questions
-
What analysts cover Lipella Pharmaceuticals Inc.?
Lipella Pharmaceuticals Inc. has been rated by research analysts at Maxim Group in the past 90 days.